Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six analysts that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $30.83.
OPCH has been the topic of several analyst reports. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and set a $27.00 price target for the company. in a report on Monday. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday. Finally, Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday.
Check Out Our Latest Stock Analysis on OPCH
Insider Buying and Selling
Institutional Trading of Option Care Health
Several hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Massachusetts Financial Services Co. MA acquired a new stake in Option Care Health during the 2nd quarter valued at $68,003,000. Magnetar Financial LLC increased its holdings in Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after buying an additional 1,377,929 shares during the last quarter. Duquesne Family Office LLC increased its stake in Option Care Health by 172.8% during the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after purchasing an additional 1,185,613 shares during the last quarter. Hood River Capital Management LLC lifted its holdings in Option Care Health by 77.2% in the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after acquiring an additional 753,208 shares during the last quarter. Finally, Westfield Capital Management Co. LP lifted its holdings in shares of Option Care Health by 15.4% in the 1st quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after purchasing an additional 688,653 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.
Option Care Health Trading Down 5.4 %
OPCH traded down $1.31 during trading on Monday, hitting $22.80. 260,433 shares of the stock were exchanged, compared to its average volume of 1,467,324. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. The firm has a 50 day simple moving average of $30.49 and a 200 day simple moving average of $29.91. Option Care Health has a 1 year low of $22.54 and a 1 year high of $34.63. The firm has a market cap of $3.88 billion, a price-to-earnings ratio of 19.16, a P/E/G ratio of 1.74 and a beta of 1.32.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
- Five stocks we like better than Option Care Health
- The Most Important Warren Buffett Stock for Investors: His Own
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- The 3 Best Fintech Stocks to Buy Now
- 3 Stocks That Are Potential Takeover Targets in 2025
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.